文献速递外周动脉疾病

机构手术量对PAD腔内治疗后关键院内并发症的影响:日本全国注册分析

Impact of Institutional Volume on Critical In-Hospital Complications Adjusted for Patient- and Limb-Related Characteristics: An Analysis of a Nationwide Japanese Registry of Endovascular Interventions for PAD.
PubMed 文献 · J Endovasc Ther · 2020-05-21

基于日本J-EVT注册2012-2017年92,224例症状性PAD腔内治疗病例,关键院内并发症(紧急手术或30天内死亡)估计发生率为0.3%(95%CI 0.3%-0.4%)。识别出10项患者及肢体相关独立危险因素,并发现机构年手术量最高四分位(≥158例/年)与关键院内并发症风险显著降低独立相关(OR 0.13,95%CI 0.07-0.23)。

要点

  • PAD腔内治疗后关键院内并发症发生率约0.3%,紧急血运重建者风险最高(OR 5.10)。
  • 年手术量≥158例的机构关键并发症风险显著低于最低四分位(OR 0.13)。
  • CLTI、TASC II D型主髂或股腘病变及女性、高龄等均为独立危险因素。

核心结论

  • 症状性PAD腔内治疗后0.3%发生关键院内并发症,较高机构手术量与较低风险独立相关。

研究设计与样本

  • 基于日本全国性外周介入注册J-EVT 2012-2017年数据,纳入92,224例因CLTI或间歇性跛行行EVT的病例,采用多变量logistic回归(多重插补缺失数据)分析。

主要发现

  • 关键院内并发症(紧急手术或30天内死亡复合终点)估计发生率为0.3%(95%CI 0.3%-0.4%)。
  • 独立危险因素包括女性(OR 1.75,95%CI 1.36-2.25)、年龄≥75岁(OR 1.60,95%CI 1.06-2.40)、CLTI(OR 2.12,95%CI 1.47-3.05)、非行走状态(OR 1.66,95%CI 1.23-2.24)、规律透析(OR 1.35,95%CI 1.02-1.77)、脑血管病(OR 1.76,95%CI 1.33-2.33)、紧急血运重建(OR 5.10,95%CI 3.64-7.13)、主髂TASC II D病变(OR 3.65,95%CI 2.51-5.33)、股腘TASC II D病变(OR 1.77,95%CI 1.24-2.52)、膝下TASC D病变(OR 1.52,95%CI 1.08-2.13)。
  • 机构年手术量第4四分位(≥158例/年)相比第1四分位关键院内并发症风险显著降低(OR 0.13,95%CI 0.07-0.23),第2、3四分位无显著差异。

关键数值与推荐

  • 机构年手术量≥158例/年(第4四分位)与最低四分位相比,关键院内并发症调整OR 0.13(95%CI 0.07-0.23)。
  • 紧急血运重建调整OR 5.10(95%CI 3.64-7.13),为风险最高的独立因素。

临床怎么用

  • 对合并多项独立危险因素(如CLTI、紧急血运重建、TASC D病变、透析、高龄女性)的PAD患者,应充分评估腔内治疗围术期风险。
  • 在低手术量机构开展PAD腔内治疗时,需关注关键院内并发症风险,可考虑优化转诊或集中化策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the incidence and clinical predictors, including institutional annual case volume, of critical in-hospital complications after endovascular therapy (EVT) for peripheral artery disease (PAD). MATERIALS AND METHODS: The data were extracted from the nationwide registry of peripheral interventions in Japan [Japanese EVT (J-EVT)] between 2012 and 2017. A total of 92,224 EVT cases either for chronic limb-threatening ischemia (CLTI) or intermittent claudication were included in the analysis. The primary outcome measure was critical in-hospital complications, which were defined as a composite of urgent surgery and in-hospital death within 30 days after EVT. The institutional volume was classified into quartiles. The association of institutional volume, as well as baseline characteristics, with the critical in-hospital complications was explored using a multivariable logistic regression model with multiple imputation for missing data. Results are presented as the adjusted odds ratio (OR) with the 95% confidence intervals (CI). RESULTS: The estimated prevalence of critical in-hospital complications was 0.3% (95% CI 0.3% to 0.4%). The following 10 patient- and limb-related characteristics were identified as independent risk factors for critical in-hospital complications: (1) female sex (OR 1.75, 95% CI 1.36 to 2.25), (2) age ≥75 years (OR 1.60, 95% CI 1.06 to 2.40), (3) CLTI (OR 2.12, 95% CI 1.47 to 3.05), (4) nonambulatory status (OR 1.66, 95% CI 1.23 to 2.24), (5) regular dialysis (OR 1.35, 95% CI 1.02 to 1.77), (6) cerebrovascular disease (OR 1.76, 95% CI 1.33 to 2.33), (7) urgent revascularization (OR 5.10, 95% CI 3.64 to 7.13), (8) aortoiliac TASC II D lesion (OR 3.65, 95% CI 2.51 to 5.33), (9) femoropopliteal TASC II D lesion (OR 1.77, 95% CI 1.24 to 2.52), and (10) infrapopliteal TASC D lesion (OR 1.52, 95% CI 1.08 to 2.13). In addition, the 4th quartile of the institutional volume (≥158 cases/year), but not the 2nd or 3rd quartile, had a significantly and independently lower risk of critical in-hospital complications than the 1st quartile (OR 0.13, 95% CI 0.07 to 0.23). CONCLUSION: After EVT for symptomatic PAD, 0.3% of the population encountered critical in-hospital complications. A higher institutional volume was significantly associated with a lower risk of critical in-hospital complications.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Iida O, Takahara M, Kohsaka S, et al. Impact of Institutional Volume on Critical In-Hospital Complications Adjusted for Patient- and Limb-Related Characteristics: An Analysis of a Nationwide Japanese Registry of Endovascular Interventions for PAD. J Endovasc Ther. 2020. PMID: 32436810. doi:10.1177/1526602820923118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。